Our data showed that both SDUY429 and SDUY436 reduced the expression of pAKTS473, implying their anti-migratory and anti-invasive efficacy against breast cancer by downregulating the AKT/GSK3β/β-catenin axis. Here, GSK3B is linked to breast carcinoma.